[Clinical observation of the lead discharging effect of paiqian chewing tablet]

Jian-zhong Lu1, Yu Cai, Yi-bin Lu

  • 1Center of Technology, Jiangzhong Pharmaceutical Co. Ltd., Nanchang 330077.

Insights

Paiqian chewing tablet (PQCT) effectively enhances lead excretion in children without impacting essential mineral levels. This study confirms PQCT

Area of Science:

  • Environmental Health
  • Pediatric Toxicology
  • Pharmacology

Background:

  • Lead exposure in children poses significant health risks.
  • Elevated blood lead levels necessitate effective interventions for lead detoxification.
  • Current treatments for lead poisoning require careful consideration of efficacy and safety.

Purpose of the Study:

  • To evaluate the efficacy of paiqian chewing tablet (PQCT) in promoting lead excretion in children.
  • To assess the safety profile of PQCT regarding essential mineral balance and overall health.
  • To determine if PQCT can safely reduce elevated blood lead levels.

Main Methods:

  • A randomized controlled trial involving 94 children with blood lead levels >100 microg/L.
  • Comparison between an observed group receiving PQCT and a control group over a 30-day period.
  • Monitoring of urinary lead output, and routine blood and urine indexes.

Main Results:

  • Significantly increased urinary lead output in the PQCT group compared to the control group at days 20 and 30 (P < 0.05, P < 0.01).
  • PQCT demonstrated a marked improvement in total urinary lead excretion (P < 0.05).
  • No adverse effects on urinary calcium and zinc excretion were observed.

Conclusions:

  • Paiqian chewing tablet (PQCT) is effective in enhancing lead discharging in children.
  • PQCT shows a favorable safety profile, with no negative impact on essential mineral excretion.
  • The study indicates that PQCT is harmless for children with elevated lead levels.
Abstract

Related Concept Videos